UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial

Journal of the American College of Cardiology, 2013-06, Vol.61 (24), p.2406-2416

2013

Volltextzugriff (PDF)

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial

BMC cardiovascular disorders, 2023-05, Vol.23 (1), p.238-238, Article 238

2023

Volltextzugriff (PDF)

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association, 2018-02, Vol.7 (3), p.n/a

2018

Volltextzugriff (PDF)

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial

Journal of the American College of Cardiology, 2012-04, Vol.59 (15), p.1350-1361

2012

Volltextzugriff (PDF)

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry

International journal of cardiology, 2014-10, Vol.176 (3), p.885-890

2014

Volltextzugriff (PDF)

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.462-469

2018

Volltextzugriff (PDF)

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study

JACC. Cardiovascular interventions, 2018-03, Vol.11 (5), p.448-459

2018

Volltextzugriff (PDF)

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT

International journal of cardiology, 2018-10, Vol.268, p.11-17

2018

Volltextzugriff (PDF)

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

EuroIntervention, 2009-09, Vol.5 (4), p.505

2009

Volltextzugriff (PDF)

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial

The American heart journal, 2015-01, Vol.169 (1), p.69-77

2015

Volltextzugriff (PDF)

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials

JACC. Cardiovascular interventions, 2016-03, Vol.9 (6), p.553-561

2016

Volltextzugriff (PDF)

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents

JACC. Cardiovascular interventions, 2020-04, Vol.13 (7), p.820

2020

Volltextzugriff (PDF)

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015-06, Vol.11 (2), p.180

2015

Volltextzugriff (PDF)

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-07, Vol.12 (4), p.431

2016

Volltextzugriff (PDF)

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2015-03, Vol.10 (11), p.1276

2015

Volltextzugriff (PDF)

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2016-04, Vol.11 (13), p.1487

2016

Volltextzugriff (PDF)

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

The American journal of cardiology, 2012-12, Vol.110 (11), p.1561-1567

2012

Volltextzugriff (PDF)

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2014-10, Vol.10 (6), p.664

2014

Volltextzugriff (PDF)

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease

Atherosclerosis, 2024-05, Vol.392, p.117488-117488, Article 117488

2024

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCatheterization And Cardiovascular Interventions

ThemaPercutaneous Coronary Intervention

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Cardiac & Cardiovascular Systems
(20)
Cardiovascular System & Cardiology
(20)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Female
(16)
Male
(16)
Middle Aged
(15)
Aged
(13)
Drug-Eluting Stents
(13)
Treatment Outcome
(13)
Risk Factors
(10)
Drug-Eluting Stent
(9)
Coronary Artery Disease - Therapy
(8)
Time Factors
(8)
Percutaneous Coronary Intervention - Adverse Effects
(7)
Sirolimus - Analogs & Derivatives
(7)
Follow-Up Studies
(6)
Prospective Studies
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Outcome Following Stringent Discontinuation of Dual Antiplatelet Therapy After 12 Months in Real-World Patients Treated With Second-Generation Zotarolimus-Eluting Resolute and Everolimus-Eluting Xience V Stents: 2-Year Follow-Up of the Randomized TWENTE Trial

Impact of a comprehensive cardiac rehabilitation programme versus coronary revascularisation in patients with stable angina pectoris: study protocol for the PRO-FIT randomised controlled trial

Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial

Impact of previous coronary artery bypass surgery on clinical outcome after percutaneous interventions with second generation drug-eluting stents in TWENTE trial and Non-Enrolled TWENTE registry

5-Year Outcome Following Randomized Treatment of All-Comers With Zotarolimus-Eluting Resolute Integrity and Everolimus-Eluting PROMUS Element Coronary Stents: Final Report of the DUTCH PEERS (TWENTE II) Trial

"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study

High bleeding risk patients with acute coronary syndromes treated with contemporary drug-eluting stents and Clopidogrel or Ticagrelor: Insights from CHANGE DAPT

Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents

Clinical Events and Patient-Reported Chest Pain in All-Comers Treated With Resolute Integrity and Promus Element Stents: 2-Year Follow-Up of the DUTCH PEERS (DUrable Polymer-Based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity) Randomized Trial (TWENTE II)

Three-year clinical outcome of patients with bifurcation treatment with second-generation Resolute and Xience V stents in the randomized TWENTE trial

Sex Difference in Chest Pain After Implantation of Newer Generation Coronary Drug-Eluting Stents: A Patient-Level Pooled Analysis From the TWENTE and DUTCH PEERS Trials

1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study

Comparison of Frequency of Periprocedural Myocardial Infarction in Patients With and Without Diabetes Mellitus to Those With Previously Unknown but Elevated Glycated Hemoglobin Levels (from the TWENTE Trial)

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease

Aktive Filter

Suchergebnisse filtern